This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tinkelenberg, B. A. Articles by Ladner, R. D. Search for Related Content PubMed PubMed Citation Articles by Tinkelenberg, B. A. Articles by Ladner, R. D.

dUTPase and Uracil-DNA Glycosylase Are Central Modulators of Antifolate Toxicity in Saccharomyces cerevisiae¹

Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Stratford, New Jersey 08084 [B. A. T., R. D. L.], and Oncology Research, GlaxoSmithKline, King of Prussia, Pennsylvania 19406 [M. J. H.]

The thymidylate synthase reaction remains an important target for widely used anticancer agents; however, the clinical utility of these drugs is limited by the occurrence of cellular resistance. Despite the considerable amount of information available regarding mechanisms of drug action, the relative significance of downstream events that result in lethality remains unclear. In this study, we have developed a model system using the budding yeast Saccharomyces cerevisiae to dissect the influence of dUMP misincorporation into DNA as a contributing mechanism of cytotoxicity induced by antifolate agents. The activities of dUTPase and uracil-DNA glycosylase, key enzymes in uracil-DNA metabolism, were diminished or augmented, and the manipulated strains were analyzed for biochemical endpoints of toxicity. Cells overexpressing dUTPase were protected from cytotoxicity by their ability to prevent dUTP pool expansion and were able to recover from an early S-phase checkpoint arrest. In contrast, depletion of dUTPase activity leads to the accumulation of dUTP pools and enhanced sensitivity to antifolates. These cells were also arrested in early S-phase and were unable to complete DNA replication after drug withdrawal, resulting in lethality. Inactivation of uracil base excision repair induced partial resistance to early cytotoxicity (within 10 h); however, lethality ultimately resulted at later time points (12–24 h), presumably because of the detrimental effects of stable uracil misincorporation. Although these cells were able to complete replication with uracil-substituted DNA, they arrested at the G₂-M phase. This finding may represent a novel mechanism by which the G₂-M checkpoint is signaled by the presence of uracil-substituted DNA. Together these data provide both genetic and biochemical evidence demonstrating that lethality from antifolates in yeast is primarily dependent on uracil misincorporation into DNA, and that uracil-independent mechanisms associated with dTTP depletion play a minor role. Our findings indicate that the relative expression levels of both dUTPase and uracil-DNA glycosylase can have great influence over the efficacy of thymidylate synthase-directed chemotherapy, thereby enhancing the candidacy of these proteins as prognostic markers and alternative targets for therapeutic development.

This article has been cited by other articles:

				P. M. Wilson, W. Fazzone, M. J. LaBonte, H.-J. Lenz, and R. D. Ladner Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage Nucleic Acids Res., January 1, 2009; 37(1): 78 - 95. [Abstract] [Full Text] [PDF]

				P. M. Wilson, W. Fazzone, M. J. LaBonte, J. Deng, N. Neamati, and R. D. Ladner Novel opportunities for thymidylate metabolism as a therapeutic target Mol. Cancer Ther., September 1, 2008; 7(9): 3029 - 3037. [Abstract] [Full Text] [PDF]

				J. A. Fischer, S. Muller-Weeks, and S. J. Caradonna Fluorodeoxyuridine Modulates Cellular Expression of the DNA Base Excision Repair Enzyme Uracil-DNA Glycosylase. Cancer Res., September 1, 2006; 66(17): 8829 - 8837. [Abstract] [Full Text] [PDF]

				L. Seiple, P. Jaruga, M. Dizdaroglu, and J. T. Stivers Linking uracil base excision repair and 5-fluorouracil toxicity in yeast Nucleic Acids Res., January 10, 2006; 34(1): 140 - 151. [Abstract] [Full Text] [PDF]

				M. Guillet, P. A. Van Der Kemp, and S. Boiteux dUTPase activity is critical to maintain genetic stability in Saccharomyces cerevisiae. Nucleic Acids Res., January 1, 2006; 34(7): 2056 - 2066. [Abstract] [Full Text] [PDF]

				K. Dornfeld and M. Johnson AP endonuclease deficiency results in extreme sensitivity to thymidine deprivation Nucleic Acids Res., November 27, 2005; 33(20): 6644 - 6653. [Abstract] [Full Text] [PDF]

				P. Ferraro, G. Pontarin, L. Crocco, S. Fabris, P. Reichard, and V. Bianchi Mitochondrial Deoxynucleotide Pools in Quiescent Fibroblasts: A POSSIBLE MODEL FOR MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY (MNGIE) J. Biol. Chem., July 1, 2005; 280(26): 24472 - 24480. [Abstract] [Full Text] [PDF]

				M. Toussaint, I. Dionne, and R. J. Wellinger Limited TTP supply affects telomere length regulation in a telomerase-independent fashion Nucleic Acids Res., January 28, 2005; 33(2): 704 - 713. [Abstract] [Full Text] [PDF]

				S. E. Koehler and R. D. Ladner Small Interfering RNA-Mediated Suppression of dUTPase Sensitizes Cancer Cell Lines to Thymidylate Synthase Inhibition Mol. Pharmacol., September 1, 2004; 66(3): 620 - 626. [Abstract] [Full Text] [PDF]

				L. Li, S. H. Berger, and M. D. Wyatt Involvement of base excision repair in response to therapy targeted at thymidylate synthase Mol. Cancer Ther., June 1, 2004; 3(6): 747 - 753. [Abstract] [Full Text] [PDF]